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Abstract
Background: Paroxysmal kinesigenic dyskinesia (PKD) is a rare condition associated with heterozygous mutations in the proline-rich transmembrane protein 2
(PRRT2) gene.
Phenomenology Shown: In this article we illustrate the phenomenology of PKD in a male previously misdiagnosed with Tourette’s syndrome.
Educational Value: Regardless of the underlying phenotype, PKD is highly responsive to some antiepileptic drugs.
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A 28-year-old male with paroxysmal and short-lasting dystonia
triggered by sudden movement was evaluated at our center. Many
short-lasting dystonia events occurred per day; these were preceded
by aura-like symptoms (e.g., paresthesias in the affected limb). Con-
sciousness was preserved during these episodes and physical examina-
tion between dystonia episodes was normal. Symptom onset in this
case was at age 11. Epilepsy was suspected first; however, repeat investi-
gations with electroencephalography and neuroimaging were normal.
The patient’s presentation was previously misinterpreted as Tourette’s
syndrome despite the absence of vocal tics. This presentation is rather
compatible with paroxysmal kinesigenic dyskinesia (PKD), a rare move-
ment disorder associated in most cases with heterozygous mutations in
the proline-rich transmembrane protein 2 (PRRT2) gene (DYT10).1
Targeted analysis of this gene (both sequencing and MLPA) was normal
and whole-genome sequencing was not contributory in this case. Focal
dystonia, in either the toes or the arms, was evident after standing
up and running. In addition, running triggered generalized dystonia
with falls and impaired speech, which are unusual in PKD (Video 1).
Dystonia receded completely after treatment with carbamazepine
was initiated. This good treatment response to antiepileptic drugs
(carbamazepine or phenytoin) constitutes one of the criteria proposed
for PKD.2 Other hyperkinesias that can occur in PKD patients include
chorea and/or ballism.2,3 Aura-like symptoms (paresthesias and stiffness
Video 1. Phenomenology of Paroxysmal Kinesigenic Dyskinesia in a 28-year-
old Male. Segment 1. Mild and short-lasting posturing in the left big toe
after standing up. Running triggers generalized dystonia leading to a fall and
impaired speech; consciousness is preserved. Segment 2. This segment shows
the remarkable good response to carbamazepine.
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in the affected limb) before the attacks, as described in this case, are
very common.3 Differential diagnosis of PKD includes several acquired
conditions affecting the basal ganglia and familial conditions such as
paroxysmal exercise-induced dyskinesia, paroxysmal hypnogenic dyski-
nesia, and glucose transporter type 1 deficiency syndrome (Glut1-DS).3
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